Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations

Dennis Cho, a Senior Vice President at Twist Bioscience, sold 230 shares of common stock on March 20, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On March 20, 2025, Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp, sold 230 shares of common stock.
• The sale was executed at a price of $41.676 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Cho directly owns 111,662 shares of Twist Bioscience Corp.
• The sale was mandated by the issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and does not represent discretionary trades by the Reporting Person.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and doesn't indicate a change in the executive's outlook on the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the executive's confidence in the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Twist Bioscience, TWST, Dennis Cho, SEC Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Incentive Plans, Sell to Cover